On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...